Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

clinical trial

Wikidata entity: Q65336859



Quantities

P2899minimum age25
P1132number of participants571

P6099 clinical trial phase ... Q42824440 (phase II clinical trial) phase II clinical trial
P17 country ... Q30 (United States) United States
P582 end time ... 2016-09-01 ???
P31 instance of ... Q30612 (clinical trial) clinical trial
P131 located in the administrative territorial entity ... Q1183 (Puerto Rico) Puerto Rico
P1050 medical condition ... Q12206 (diabetes) diabetes
P4844 research intervention ... Q19484 (metformin) metformin
P6153 research site ... Q49088 (Columbia University) Columbia University
P6153 research site ... Q333886 (Georgetown University) Georgetown University
P6153 research site ... Q1472663 (University of Alabama at Birmingham) University of Alabama at Birmingham
P6153 research site ... Q30254282 (Dallas Diabetes and Endocrine Center) Dallas Diabetes and Endocrine Center
P6153 research site ... Q30265329 (BioFortis (United States)) BioFortis (United States)
P6153 research site ... Q30269674 (Collaborative Neuroscience Network) Collaborative Neuroscience Network
P6153 research site ... Q30269704 (Meridien Research) Meridien Research
P6153 research site ... Q30269900 (Heartland Clinical Research) Heartland Clinical Research
P6153 research site ... Q30270033 (PMG Research) PMG Research
P6153 research site ... Q30270351 (Progressive Clinical Research) Progressive Clinical Research
P6153 research site ... Q30270367 (Providence Clinical Research) Providence Clinical Research
P6153 research site ... Q30282209 (Sterling Research Group (United States)) Sterling Research Group (United States)
P6153 research site ... Q50036548 (Clinical Pharmacology of Miami) Clinical Pharmacology of Miami
P580 start time ... 2015-09-01 ???
P8363 study type ... Q78089383 (interventional study) interventional study
P1476 title Monolingualtext Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled, Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release In Subjects With Type 2 Diabetes Mellitus ???

External Ids
P3098ClinicalTrials.gov IDNCT02526524

Why not click here or view trends?

log id: 4764141